Loading...
By Kelly Young
Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH
The CDC is alerting healthcare providers about the detection of beta-lactamase-producing isolates of Neisseria meningitidis that were resistant to ciprofloxacin and penicillin.
From 2013 to 2020, the agency identified 33 cases of meningococcal disease caused by isolates containing a gene that was resistant to penicillins. Eleven of these reported in 2019 to 2020 were also resistant to ciprofloxacin.
The agency recommends that clinicians perform antimicrobial susceptibility testing of all meningococcal isolates to determine whether they're susceptible to penicillin before switching to penicillin or ampicillin. For states with ciprofloxacin-resistant isolates found in the past 2 years, clinicians should consider susceptibility testing when providing prophylactic treatment. However, testing shouldn't delay the start of prophylaxis with ciprofloxacin, rifampin, or ceftriaxone.
Comment
LINK(S):
CDC health advisory (Free)
MMWR article (Free)
Background: NEJM Journal Watch Infectious Diseases coverage of azithromycin as chemoprophylaxis drug for N. meningitidis (Your NEJM Journal Watch subscription required)